WO2011152692A3 - 푸코산틴을 포함하는 항-비만용 크림 조성물 - Google Patents

푸코산틴을 포함하는 항-비만용 크림 조성물 Download PDF

Info

Publication number
WO2011152692A3
WO2011152692A3 PCT/KR2011/004107 KR2011004107W WO2011152692A3 WO 2011152692 A3 WO2011152692 A3 WO 2011152692A3 KR 2011004107 W KR2011004107 W KR 2011004107W WO 2011152692 A3 WO2011152692 A3 WO 2011152692A3
Authority
WO
WIPO (PCT)
Prior art keywords
obesity
cream composition
composition containing
fucoxanthin
containing fucoxanthin
Prior art date
Application number
PCT/KR2011/004107
Other languages
English (en)
French (fr)
Other versions
WO2011152692A2 (ko
Inventor
황영재
Original Assignee
주식회사 리스토어랩스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 리스토어랩스 filed Critical 주식회사 리스토어랩스
Priority claimed from KR1020110054184A external-priority patent/KR20110133005A/ko
Publication of WO2011152692A2 publication Critical patent/WO2011152692A2/ko
Publication of WO2011152692A3 publication Critical patent/WO2011152692A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 비타민 C를 사용하는 추출 과정으로 인해 보다 안정화된 푸코산틴을 유효 성분으로 포함하는 항-비만용 크림 조성물에 관한 것이다. 본 발명의 항-비만용 크림 조성물은 백색 체지방에 있는 UCP 1 발현을 종래에 비해 현저히 증가시켜 지방 세포 아포토시스 작용을 일으킴으로써 셀룰라이트를 비롯한 지방 세포를 만족스러울 정도로 감소시킬 수 있다.
PCT/KR2011/004107 2010-06-03 2011-06-03 푸코산틴을 포함하는 항-비만용 크림 조성물 WO2011152692A2 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2010-0052514 2010-06-03
KR20100052514 2010-06-03
KR10-2011-0054184 2011-06-03
KR1020110054184A KR20110133005A (ko) 2010-06-03 2011-06-03 푸코산틴을 포함하는 항-비만용 크림 조성물

Publications (2)

Publication Number Publication Date
WO2011152692A2 WO2011152692A2 (ko) 2011-12-08
WO2011152692A3 true WO2011152692A3 (ko) 2012-04-19

Family

ID=45067212

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/004107 WO2011152692A2 (ko) 2010-06-03 2011-06-03 푸코산틴을 포함하는 항-비만용 크림 조성물

Country Status (1)

Country Link
WO (1) WO2011152692A2 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103012327B (zh) * 2012-12-21 2015-05-13 国家海洋局第三海洋研究所 岩藻黄质的制备方法
WO2014138426A2 (en) * 2013-03-07 2014-09-12 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
FR3126870A1 (fr) 2021-09-16 2023-03-17 Gozen K. K. Japan Composition pharmaceutique ou cosmétique destinée à améliorer la cellulite et les varices caractérisée en ce qu’elle comprend une association de théanine et des polysaccharides issus du matcha.

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050039283A (ko) * 2003-10-24 2005-04-29 목도창조 주식회사 갈조류를 이용한 푸코잔틴의 추출방법
EP1884238A1 (en) * 2005-05-24 2008-02-06 National University Corporation Hokkaido University Agent having antiobesity activity and method of inhibiting obesity
US20080206275A1 (en) * 2006-12-08 2008-08-28 Zakir Ramazanov Composition for treating obesity and method of using the same
US20080233209A1 (en) * 2007-03-22 2008-09-25 Polifenoles Naturales, Sl Composition and method of use for the treatment of metabolic syndrome and inflammation
JP2008280281A (ja) * 2007-05-10 2008-11-20 Hokkaido Univ 抗肥満活性剤
WO2009048249A2 (en) * 2007-10-10 2009-04-16 Amicogen, Inc. Composition for preventing or treating lipid metabolic disorders comprising fucoxanthin or marine plant extract containing same

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050039283A (ko) * 2003-10-24 2005-04-29 목도창조 주식회사 갈조류를 이용한 푸코잔틴의 추출방법
EP1884238A1 (en) * 2005-05-24 2008-02-06 National University Corporation Hokkaido University Agent having antiobesity activity and method of inhibiting obesity
US20080206275A1 (en) * 2006-12-08 2008-08-28 Zakir Ramazanov Composition for treating obesity and method of using the same
US20080233209A1 (en) * 2007-03-22 2008-09-25 Polifenoles Naturales, Sl Composition and method of use for the treatment of metabolic syndrome and inflammation
JP2008280281A (ja) * 2007-05-10 2008-11-20 Hokkaido Univ 抗肥満活性剤
WO2009048249A2 (en) * 2007-10-10 2009-04-16 Amicogen, Inc. Composition for preventing or treating lipid metabolic disorders comprising fucoxanthin or marine plant extract containing same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
H. MAEDA ET AL.: "Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 332, 2005, pages 392 - 397 *
K. KANAZAWA ET AL.: "Commercial-scale preparation of biofunctional fucoxanthin from waste parts of brown sea algae Laminalia japonica", FOOD SCIENCE AND TECHNOLOGY RESEARCH, vol. 14, no. 6, 2008, pages 573 - 582 *
M. WRONA ET AL.: "Zeaxanthin in combination with ascorbic acid or alpha-tocopherol protects ARPE-19 cells against photosensitized peroxidation of lipids", FREE RADICAL BIOLOGY & MEDICINE, vol. 36, no. 9, 2004, pages 1094 - 1101 *

Also Published As

Publication number Publication date
WO2011152692A2 (ko) 2011-12-08

Similar Documents

Publication Publication Date Title
WO2013027984A3 (ko) 녹차 성분을 함유하는 화장료 조성물
WO2010027792A8 (en) Treatment of sweating and hyperhidrosis
WO2013062266A3 (ko) 약용 꽃을 활용한 쌈 발효법 및 이를 활용한 피부 외용제 조성물
WO2011126295A3 (ko) 약용 잎을 활용한 쌈 발효법 및 이를 활용한 피부 외용제 조성물
WO2011122869A3 (ko) 쿠메스트롤 또는 쿠메스트롤을 포함하는 콩 추출물을 포함하는 피부 미용용 조성물
PH12015502542A1 (en) Stabilized pemetrexed formulation
WO2009112590A3 (en) Substances raising the activation threshold of immune cell
WO2012002730A3 (ko) 봉독 추출물을 함유하는 피부 미백 및 보습용 조성물
EP3067059A4 (en) Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient
WO2014167247A3 (fr) Composition cosmetique, pharmaceutique ou alimentaire comprenant un extrait riche en carotenoides d'arthrobacter agilis
WO2012067404A3 (ko) 청호쑥 추출물을 유효성분으로 함유하는 항노화용 조성물
WO2014035971A3 (en) Chlorhexidine gluconate solubilized in a hydrophobic monoacylglyceride
MX357554B (es) Concentrado o extracto de brote de aloe vera que tiene efectos superiores de promoción de célula de la piel, antioxidantes y anti-alergia.
EP4282272A3 (en) Method of delivering an agriculturally active ingredient
WO2012070804A3 (ko) 올레아놀릭산을 함유하는 화장료 조성물
WO2013060707A3 (de) Kosmetische mittel enthaltend oxytocin und riechstoffe
MY163476A (en) Oral care compositions
WO2012173458A3 (ko) 식물 세포 내에 안정화된 활성 물질 및 그 제조방법
WO2011145872A3 (ko) 탈모방지 또는 육모 촉진용 조성물
WO2014037903A3 (en) Cosmetic compositions comprising eicosapentaeninic free acid and gamma-linopenic free acid and methods of making and using same
WO2013028904A3 (en) Dermal filler compositions including antioxidants
MX357704B (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
WO2011152692A3 (ko) 푸코산틴을 포함하는 항-비만용 크림 조성물
WO2012173382A3 (ko) 탄시논ⅱａ를 유효성분으로 함유하는 피부 외용제 조성물
WO2014023649A3 (en) Dermal cosmetic compositions having osmoprotecting activity

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11790050

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11790050

Country of ref document: EP

Kind code of ref document: A2